Corporate Information And Statement Of Ifrs Compliance [Abstract]

Tchaikapharma High Quality Medicines AD - Filing #6023728

Concept	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification	—	The Tchaikapharma High Quality Medicines Inc. group does not have a parent ultimate	—
Domicile of entity	—	1,172	—
Legal form of entity	—		—
Principal place of business	—	Republic of Bulgaria	—
Description of nature of entity's operations and principal activities	—	purchase	—
Name of parent entity	—		—
Statement of IFRS compliance [text block]	—		—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]	—	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current inventories	14 303 BGN	—	13 480 BGN
Current trade payables	4 768 BGN	—	5 080 BGN
Disclosure of objectives, policies and processes for managing capital [text block]	—	Capital risk management	—